4 Healthcare Stock Stories for Tuesday Wellness
February 05, 2013
Hyperion Therapeutics (HPTX) Closing price $19.07
The firm reports that the FDA has okayed Ravicti for the treatment of urea cycle disorders in patients two years of age and older. The medication should be commercially available by the end of April.
Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.
Premium Newsletters
Gold & Silver
Don't miss one of the biggest bull markets in history! Covers Gold, Silver, Gold & Silver stocks, and miners.
Learn More
Commodities Premium
There's always a bull market in some sector! Find the best opportunities in commodities.
Learn more
ETF Investing
At last, a trading system that buys the right ETFs at the right time, time after time!
Learn more
Wall St. Cheat Sheet has been featured in these fine media outlets:
